Alkeon Capital Management’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,743,505
Closed -$14.1M 104
2024
Q1
$14.1M Sell
2,743,505
-370,059
-12% -$2.28M 0.08% 89
2023
Q4
$17.8M Buy
3,113,564
+1,468,701
+89% +$7.26M 0.12% 85
2023
Q3
$7.86M Buy
1,644,863
+287,800
+21% +$1.79M 0.05% 96
2023
Q2
$5.77M Buy
1,357,063
+302,418
+29% +$1.36M 0.03% 110
2023
Q1
$5.6M Sell
1,054,645
-3,958
-0.4% -$24.7K 0.04% 119
2022
Q4
$6.65M Sell
1,058,603
-163,488
-13% -$1.45M 0.05% 119
2022
Q3
$12.9M Buy
1,222,091
+348,542
+40% +$3.25M 0.09% 118
2022
Q2
$4.74M Sell
873,549
-350,000
-29% -$2.68M 0.03% 134
2022
Q1
$11.2M Sell
1,223,549
-23,076
-2% -$243K 0.05% 131
2021
Q4
$18.8M Hold
1,246,625
0.06% 127
2021
Q3
$29.8M Buy
+1,246,625
New +$30.5M 0.1% 126

Other funds holding CRBU